GEODE CAPITAL MANAGEMENT, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 55 filers reported holding RAPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,453,347
+2.8%
628,886
+15.6%
0.00%0.0%
Q2 2023$10,171,871
+4.9%
543,950
+2.9%
0.00%0.0%
Q1 2023$9,698,990
+107582.8%
528,555
+16.2%
0.00%0.0%
Q4 2022$9,007
-99.9%
454,906
+7.0%
0.00%
-50.0%
Q3 2022$10,228,000
+37.9%
425,143
+4.6%
0.00%
+100.0%
Q2 2022$7,417,000
-9.0%
406,432
+9.7%
0.00%0.0%
Q1 2022$8,149,000
-35.5%
370,591
+7.7%
0.00%
-50.0%
Q4 2021$12,635,000
+17.3%
344,014
-0.8%
0.00%
+100.0%
Q3 2021$10,770,000
+48.9%
346,867
+52.4%
0.00%0.0%
Q2 2021$7,235,000
+92.3%
227,588
+34.3%
0.00%0.0%
Q1 2021$3,763,000
+32.4%
169,513
+17.7%
0.00%
Q4 2020$2,843,000
-35.9%
143,975
+4.4%
0.00%
-100.0%
Q3 2020$4,438,000
+16.4%
137,844
+4.9%
0.00%0.0%
Q2 2020$3,813,000
+154.2%
131,396
+86.2%
0.00%
Q1 2020$1,500,000
-8.1%
70,552
+19.2%
0.00%
Q4 2019$1,632,00059,1720.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$58,747,00054.16%
KPCB XV Associates, LLC 1,297,063$47,641,00037.58%
Ponoi II Management, LLC 145,401$5,341,0009.70%
Euclidean Capital LLC 432,900$15,900,0009.04%
Column Group LLC 1,402,008$51,496,0007.00%
AJU IB Investment Co., Ltd. 99,503$3,655,0005.09%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,148,321$42,178,0004.85%
Ghost Tree Capital, LLC 350,000$12,856,0004.61%
Velan Capital Investment Management LP 110,000$4,040,0003.14%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$16,294,0002.28%
View complete list of RAPT THERAPEUTICS INC shareholders